Esperer Onco Nutrition (EON) announced the appointment of two new senior members for their Research and Development (R&D) team.
Joining the organization are Dr. Vivek Srivastav and Dr. Anubhab Mukherjee. Dr. Srivastav will serve as the Vice-President of the R&D and Operation. Dr. Mukherjee will be serving as the Principal Scientist of the Research and Development division. “We at Esperer are glad to welcome resourceful intelligentsia in our crucial research and development department. I am sure both Dr Srivastav and Dr Mukherjee will foster and hone the best research practices and help Esperer Onco Nutrition to develop better mediums to offer nutrition at all stages of the critical disease management focussed on cancer”, said Mr. Raktim Chattopadhyay, Founder & CEO at Esperer Onco Nutrition.
Prior to joining EON, Dr. Vivek Srivastav was the Director-Research & Development (Enteral Nutrition), North-East South-East Asia (NESEA), Member of Leadership Team at Fresenius Kabi India Pvt. Ltd. With his strong research experience, Dr Vivek carries MD with PhD in Phytonutrients as education. He promises to add value to the mission of EON as a research organization. Dr. Srivastav said, “I am excited to explore this new opportunity with EON. The vison of whole group and management focus on building science based formulations attracted me the most towards EON.I feel my experience as a researcher coupled with some hands-on experience in corporate functions like regulatory affairs, business development and drug planning could be utilized for the growth of the organization.”
Dr. Anubhab Mukherjee joins as a Principal Scientist, R&D in Esperer Onco Nutrition (EON) Pvt. Ltd and heads the Hyderabad R&D center for the organization as well. He has a Ph.D. from CSIR-Indian Institute of Chemical Technology, India. He has in-depth experience in the cancer &Nanomedicine space and has been a part of two post-doctoral research in the United States of America (USA). At EON he plans to spearhead the quest for ultimate nutritional care through different delivery mechanisms for cancer patients. A super specialized researcher, academician and scientist Dr. Mukherjee says, “I am motivated to work with Esperer Onco Nutrition and lead a team of bright scientists whose inputs can help me steer my existing knowledge for the larger good of humanity. I am happy EON has given me this career proposal. I may not find the cure, but possibly a better coping mechanism for life with cancer can definitely be my deliverable”.
“As the time has come to prioritise Research in Nutraceutical to put India ahead”, says Founder &CEO Mr. Raktim Chattopadhyay, “I take Esperer Onco Nutrition one step ahead with Dr. Vivek Srivastav and Dr.Anubhab Mukherjee and wish them best of luck for their innovation ”
Esperer Nutrition strives to champion the role of nutritional therapies that have proven clinical & health economic value, & improve the quality of people’s lives. EON is destined to understand, treat & help prevent a range of medical conditions by leveraging nutrition and life sciences.
Company aims to address specific health conditions with special emphasis on Onco Nutrition & intend to provide a 360 degree solution to global cancer portfolio right from Preventive Oncology to Cancer Disease Management using Nutraceutical as complementary therapy to stage & region specific cancer patients.
EON aspire to become global pioneer considering Drug-Nutrient Interaction as major factor in chronic disease management.